Rankings
▼
Calendar
TARS Q2 2020 Earnings — Tarsus Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
TARS
Tarsus Pharmaceuticals, Inc.
$3B
Q2 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$3M
Net Income
-$3M
EPS (Diluted)
$-0.30
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$3M
Free Cash Flow
-$3M
Stock-Based Comp.
$173,000
Balance Sheet
Total Assets
$56M
Total Liabilities
$4M
Stockholders' Equity
$52M
Cash & Equivalents
$53M
← FY 2020
All Quarters
Q3 2020 →
